Publication | Closed Access

Effect of denosumab administration on low bone mineral density (T-score −1.0 to −2.5) in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer

Bone DiseaseBreast OncologyBone HealthOncologyNon-metastatic Breast CancerDenosumab AdministrationMedicineAromatasePharmacotherapyBreast CancerMenopauseAdjuvant Aromatase InhibitorsMetabolic Bone DiseasePharmacologyRadiation OncologyOsteoporosisMenopause Hormone Therapy